A1-adrenergic antagonists
Doxazosin:
First dose phenomenon, especially syncope may occur
Therefore it is important to assess BP prior to and during therapy
Assess for common SE such as weakness, dizziness, headache, N/V
Older adults especially prone to hypotensive and hypothermic effects related to vasodilation
Indications:
HTN
Benign prostatic hyperplasia and urinary obstruction because they relax smooth muscle in the prostate and bladder neck, thus reducing urethral resistance
Mechanism of action:
Dilates arteries and veins by blocking postsynaptic a-1 adrenergic receptors in vascular smooth muscle causing muscle to relax
Desired effects:
Decrease afterload (SVR)
Decrease BP
Increase urine flow and decrease sx of BPH
Adverse effects:
Dizziness, weakness, drowsiness, headache, orthostatic hypotension, palpitations, chest pain, edema, dysrythmias, N/V, diarrhea, constipation, abdominal pain